{"id":"W2935541805","doi":"10.1016/s1470-2045(19)30029-4","title":"Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":537,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Ovarian cancer; BRCA mutation; Oncology; Progressive disease; Chemotherapy; Progression-free survival; Population; Phases of clinical research; Carboplatin; Combination therapy; Surgery; Gastroenterology; Cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001928591,0.001705872,0.002393517,0.0003101255,0.0003283363,0.001262568,0.0009598502,0.001285685,0.006473244],"category_scores_gemma":[0.001351116,0.0005693685,0.002106661,0.0003232713,0.0009864734,0.001333527,0.0005211699,0.004241631,0.001454577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007561734,"about_ca_system_score_gemma":0.001069702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000469753,"about_ca_topic_score_gemma":0.001763358,"domain_scores_codex":[0.9995617,0.0002198275,0.00001800556,0.00009277234,0.0000292941,0.00007836062],"domain_scores_gemma":[0.9992812,0.0001526243,0.0001321538,0.00007870827,0.00003446132,0.0003209149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9027153,0.01189507,0.001600801,0.001299042,0.001930384,0.0001151338,0.0001324618,0.001486623,0.008514596,0.0004152358,0.005288338,0.06460706],"study_design_scores_gemma":[0.9092796,0.08368403,0.00268862,0.00004545389,0.0003594084,0.0001787627,0.00003254648,0.0007521539,0.0004609305,0.0003777174,0.002113242,0.0000275125],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.976484,0.008809147,0.001442746,0.001918216,0.0007194831,0.003005103,0.003590187,0.0003080137,0.003723062],"genre_scores_gemma":[0.9720392,0.005386302,0.004150069,0.002833912,0.0004526132,0.003472902,0.004973596,0.00009775107,0.006593716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006473244,"threshold_uncertainty_score":0.02165514,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2455515079193662,"score_gpt":0.4816545343169153,"score_spread":0.2361030263975491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}